The group reported that ST2 expression was minimal on glioma cells and that nuclear IL-33 mediated the release of inflammatory cytokines from glioma cells and was required for the recruitment of M2 protumorigenic macrophages (85). The gene discussed is IL33; the disease is central nervous system cancer.